Organovo's bioprinter for new tissue and EStimME expands into middle ear drug delivery
This article was originally published in Clinica
Executive Summary
Clinica’s Patent Watch focuses on key growth areas of regenerative medicine, or where there is potential to selectively treat disease with drugs in personalised treatments, as is the case with emerging areas of drug delivery and molecular diagnostics. New patent applications published in September/October 2011 include a new bioprinter for manufacturing replacement tissues and organs, drug delivery technology for middle ear conditions and a rapid test which may help in the early detection of prostate cancer.